APA

Iwakiri K., Sakurai Y., Shiino M., Okamoto H., Kudou K., Nishimura A., Hiramatsu N., Umegaki E. & Ashida K. (2017). A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis. : Therapeutic advances in gastroenterology.

Chicago

Iwakiri Katsuhiko, Sakurai Yuuichi, Shiino Madoka, Okamoto Hiroyuki, Kudou Kentaro, Nishimura Akira, Hiramatsu Naoki, Umegaki Eiji and Ashida Kiyoshi. 2017. A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis. : Therapeutic advances in gastroenterology.

Harvard

Iwakiri K., Sakurai Y., Shiino M., Okamoto H., Kudou K., Nishimura A., Hiramatsu N., Umegaki E. and Ashida K. (2017). A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis. : Therapeutic advances in gastroenterology.

MLA

Iwakiri Katsuhiko, Sakurai Yuuichi, Shiino Madoka, Okamoto Hiroyuki, Kudou Kentaro, Nishimura Akira, Hiramatsu Naoki, Umegaki Eiji and Ashida Kiyoshi. A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis. : Therapeutic advances in gastroenterology. 2017.